ESMO Public Policy Committee

ESMO represents its members at the political level, working to keep cancer a high priority on the European healthcare agenda.

The ESMO Public Policy Committee addresses political topics of concern to ESMO and its members, with a specific focus on promoting the practice and the profession of medical oncology and diminishing the discrepancies in the quality of cancer care. The Committee collaborates closely with leading oncology societies and coordinates its activities with key stakeholders to assure that the oncology community speaks with one united voice.

Activities and responsibilities:

  • Gain widespread, full recognition and implementation of medical oncology to assure better multidisciplinary treatment of cancer patients
  • Diminish discrepancies in quality of cancer care through the proper development and dissemination of evidence-based clinical practice guidelines
  • Establish collaborative networks for cancer care to enhance equal patient access to treatment and care
  • Obtain a uniform approval and reimbursement process in Europe for effective anticancer agents
  • Improve the frameworks for clinical and translational cancer research to support rapid advancement of new cancer therapies
  • Improve health care and research for rare cancers to assure timely and correct diagnosis of patients and their access to the best available care

Structure:

Chair

  • Paolo Casali, Italy

Core Committee Members

  • Adamos Adamou, Cyprus
  • Jean-Yves Blay, France
  • Michel Coleman, United Kingdom
  • John Crown, Ireland
  • Christian Dittrich, Austria
  • Alexandru Enui, Romania
  • Rosa Giuliani, Italy
  • Margaret Hutka, United Kingdom
  • Jose Martin-Moreno, Spain
  • Hans-Jörg Senn, Switzerland
  • Simon Van Belle, Belgium

Extended Committee Members          

  • Breast cancer: Serena Di Cosimo, Italy
  • Cancer genetics: James Mackay, United Kingdom
  • Cancer in the elderly: Matti Aapro, Switzerland
  • Clinical trials: Marc Buyse, Belgium
  • CNS tumours: Andreas Hottinger, Switzerland
  • Community oncology: Michalis Karamouzis, Greece
  • Community oncology: Stefan Rauh, Luxembourg
  • GI cancers: Andres Cervantes, Spain
  • Gynecological cancers: Antonio Gonzalez-Martin, Spain
  • H&N cancers: Lisa Licitra, Italy
  • Haematological cancers: Harry Schouten, Netherlands
  • Lung cancer: Marina Garassino, Italy
  • Melanoma: Lorenz Jost, Switzerland
  • Neuroendocrine tumours: Karim Fizazi, France
  • Palliative care: Simon Van Belle, Belgium
  • Pathology: Angelo Paolo Dei Tos, Italy
  • Prevention: Hans-Jörg Senn, Switzerland
  • Prevention: Lawrence von Karsa, France
  • Regulatory affairs: Rosa Giuliani, Italy
  • Sarcoma: Jean-Yves Blay, France
  • Urogenital cancers: Cora Sternberg, Italy